Dynavax Reports First Quarter 2025 Financial Results and Announces New Pipeline Programs

Go back to Dynavax Reports First Quarter 2025 Financial Results and Announces New Pipeline Programs

Dynavax (DVAX) Misses Q1 EPS by 81c, Misses on Revenue

May 6, 2025 4:04 PM EDT

Dynavax (NASDAQ: DVAX) reported Q1 EPS of ($0.77), $0.81 worse than the analyst estimate of $0.04. Revenue for the quarter came in at $65 million versus the consensus estimate of $67.86 million.

For earnings history and earnings-related data on Dynavax (DVAX) click here.

... More